Business

Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio

Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business Darmstadt, Germany, April 01, 2026 (GLOBE NEWSWIRE) -- Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturingIntegrated downstream workflows to improve productivity and help speed access to critical therapies Merck, a leading science and technology company, today announced that it has succe

articleMerck & Company, Inc.April 1, 20262/company/merck-and-company-inc/news/merck-completes-acquisition-of-jsr-life-sciences-chromatography-business-expanding-protein-a-capabilities-and-downstream-portfolio
Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio

About this update from Merck & Company, Inc.

[{"type":"text","content":"Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business","length":73,"tagName":"p"},{"type":"image","alt":"Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business","displaySize":"","headline":null,"caption":"Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":800,"height":533,"url":"https://media.zenfs.com/en/globenewswire.com/6dec9cdedac9441a883c299ca8c4913a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/4sutvJH02ewPnMjy629t5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/6dec9cdedac9441a883c299ca8c4913a","width":800,"height":533},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/nmFbPnJUJProo4kfdrN6KA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2MDA7aD0xMDY2/https://media.zenfs.com/en/globenewswire.com/6dec9cdedac9441a883c299ca8c4913a","width":800,"height":533}}},{"type":"text","content":"Darmstadt, Germany, April 01, 2026 (GLOBE NEWSWIRE) --","length":54,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Integrated downstream workflows to improve productivity and help speed access to critical therapies","length":99,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":214,"olType":false},{"type":"text","content":"Merck, a leading science and technology company, today announced that it has successfully closed the acquisition of the chromatography business of JSR Life Sciences. The acquisition adds Amsphere™ Protein A resins and advanced Protein A chromatography capabilities to Merck’s downstream processing portfolio, enabling efficient, scalable purification of monoclonal antibodies. Combined with Merck’s established downstream portfolio, these capabilities help customers improve productivity and support reliable manufacturing from development through commercial scale.“This acquisition expands our downstream purification capabilities at a time when customers are pushing to scale biologics faster and more efficiently,” said Sebastián Arana, Head of Process Solutions, Life Science business of Merck. “With expanded Prote...

More updates from Merck & Company, Inc.

MerckChromatographydownstream processingJSR Life Sciencesmanufacturingantibody purification